Works matching IS 14628902 AND DT 2025 AND VI 27 AND IP 1

Results: 51
    1

    Effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the PRIORITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 387, doi. 10.1111/dom.16037
    By:
    • Wasehuus, Victor;
    • Rotbain Curovic, Viktor;
    • Tofte, Nete;
    • Lindhardt, Morten;
    • Currie, Gemma;
    • Delles, Christian;
    • Frimodt‐Møller, Marie;
    • Mischak, Harald;
    • von der Leyen, Heiko;
    • Hansen, Tine Willum;
    • Kümler, Thomas;
    • Persson, Frederik;
    • Rossing, Peter;
    • Stefansen, Rikke;
    • Campbell, Maria Athena;
    • Zimmermann, Silke;
    • Rädisch, Brit;
    • Hävemeier, Anika;
    • Busmann, Annette;
    • Wittkop, Ulrike
    Publication type:
    Article
    2

    Dietary potassium intake and its interaction with sodium intake on risk of developing cardiovascular disease in persons with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 12).

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 394, doi. 10.1111/dom.16035
    By:
    • Horikawa, Chika;
    • Takahara, Mitsuyoshi;
    • Katakami, Naoto;
    • Takeda, Yasunaga;
    • Takeuchi, Mizuki;
    • Fujihara, Kazuya;
    • Suzuki, Hiroaki;
    • Yoshioka, Narihito;
    • Shimano, Hitoshi;
    • Satoh, Jo;
    • Hayashino, Yasuaki;
    • Tajima, Naoko;
    • Nishimura, Rimei;
    • Yamasaki, Yoshimitsu;
    • Sone, Hirohito
    Publication type:
    Article
    3
    4
    5
    6

    A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 368, doi. 10.1111/dom.16030
    By:
    • Krebs, Jeremy D.;
    • Parry‐Strong, Amber;
    • Braakhuis, Andrea;
    • Worthington, Anna;
    • Merry, Troy L.;
    • Gearry, Richard B.;
    • Foster, Meika;
    • Weatherall, Mark;
    • Davies, Cheryl;
    • Mullaney, Jane;
    • Ross, Cecilia;
    • Conroy, Denise;
    • Rolleston, Anna;
    • Lithander, Fiona E.
    Publication type:
    Article
    7
    8
    9
    10

    The associations between functional vitamin K status and all‐cause mortality, cardiovascular disease and end‐stage kidney disease in persons with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 348, doi. 10.1111/dom.16025
    By:
    • Friis Bryde Nielsen, Camilla;
    • Møller Thysen, Sanne;
    • Bach Kampmann, Freja;
    • Hansen, Tine Willum;
    • Jørgensen, Niklas Rye;
    • Tofte, Nete;
    • Abitz Winther, Signe;
    • Theilade, Simone;
    • Rossing, Peter;
    • Frimodt‐Møller, Marie;
    • Linneberg, Allan
    Publication type:
    Article
    11
    12

    Subphenotypes of adult‐onset diabetes: Data‐driven clustering in the population‐based KORA cohort.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 338, doi. 10.1111/dom.16022
    By:
    • Dong, Qiuling;
    • Xi, Yue;
    • Brandmaier, Stefan;
    • Fuchs, Markéta;
    • Huemer, Marie‐Theres;
    • Waldenberger, Melanie;
    • Niu, Jiefei;
    • Herder, Christian;
    • Rathmann, Wolfgang;
    • Roden, Michael;
    • Koenig, Wolfgang;
    • Bönhof, Gidon J.;
    • Gieger, Christian;
    • Thorand, Barbara;
    • Peters, Annette;
    • Rospleszcz, Susanne;
    • Grallert, Harald
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Low‐calorie, high‐protein diets, regardless of protein source, improve glucose metabolism and cardiometabolic profiles in subjects with prediabetes or type 2 diabetes and overweight or obesity.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 268, doi. 10.1111/dom.16013
    By:
    • Rodrigo‐Carbó, Carmen;
    • Madinaveitia‐Nisarre, Loreto;
    • Pérez‐Calahorra, Sofía;
    • Gracia‐Rubio, Irene;
    • Cebollada, Alberto;
    • Galindo‐Lalana, Carlos;
    • Mateo‐Gallego, Rocío;
    • Lamiquiz‐Moneo, Itziar
    Publication type:
    Article
    21
    22
    23

    Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow‐up of the prospective Swedish Obese Subjects study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 238, doi. 10.1111/dom.16010
    By:
    • Carlsson, Lena M. S.;
    • Carlsson, Björn;
    • Jacobson, Peter;
    • Andersson‐Assarsson, Johanna C.;
    • Karlsson, Cecilia;
    • Kristensson, Felipe M.;
    • Ahlin, Sofie;
    • Näslund, Ingmar;
    • Karason, Kristjan;
    • Svensson, Per‐Arne;
    • Taube, Magdalena;
    • Peltonen, Markku;
    • Sjöholm, Kajsa
    Publication type:
    Article
    24

    Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation‐enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 414, doi. 10.1111/dom.16002
    By:
    • Dufrusine, Beatrice;
    • Natale, Luca;
    • Sallese, Michele;
    • Mozzillo, Enza;
    • Di Candia, Francesca;
    • Cuccurullo, Irene;
    • Iafusco, Dario;
    • Zanfardino, Angela;
    • Passariello, Luana;
    • Iannilli, Antonio;
    • Santarelli, Sara;
    • Federici, Luca;
    • De Laurenzi, Vincenzo;
    • Cherubini, Valentino;
    • Pieragostino, Damiana
    Publication type:
    Article
    25
    26
    27

    Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 215, doi. 10.1111/dom.16005
    By:
    • Amin, Neeta B.;
    • Frederich, Robert;
    • Tsamandouras, Nikolaos;
    • Haggag, Amina Z.;
    • Schuster, Tilman;
    • Zmuda, Witold;
    • Palmer, Alexandra;
    • Vasas, Szilard;
    • Buckley, Gina;
    • Smith, Timothy R.;
    • DuBrava, Sarah J.;
    • Zhu, Qi;
    • Johnson, Margot
    Publication type:
    Article
    28
    29
    30
    31

    In vivo mapping of postprandial hepatic glucose metabolism using dynamic magnetic resonance spectroscopy combined with stable isotope flux analysis in Roux‐en‐Y gastric bypass adults and non‐operated controls: A case–control study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 196, doi. 10.1111/dom.16001
    By:
    • Poli, Simone;
    • Lange, Naomi F.;
    • Brunasso, Alessandro;
    • Buser, Angeline;
    • Ballabani, Edona;
    • Melmer, Andreas;
    • Schiavon, Michele;
    • Tappy, Luc;
    • Herzig, David;
    • Dalla Man, Chiara;
    • Kreis, Roland;
    • Bally, Lia
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO‐PROFIT study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 111, doi. 10.1111/dom.15988
    By:
    • Sourij, Harald;
    • Azhar, Kehkishan;
    • Aziz, Faisal;
    • Kojzar, Harald;
    • Sourij, Caren;
    • Fasching, Peter;
    • Clodi, Martin;
    • Ludvik, Bernhard;
    • Mader, Julia K.;
    • Resl, Michael;
    • Rega‐Kaun, Gersina;
    • Ress, Claudia;
    • Stechemesser, Lars;
    • Stingl, Harald;
    • Tripolt, Norbert J.;
    • Wascher, Thomas;
    • Kaser, Susanne
    Publication type:
    Article
    44

    Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida+ clinical research network.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 102, doi. 10.1111/dom.15987
    By:
    • Li, Piaopiao;
    • Spector, Eliot;
    • Alkhuzam, Khalid;
    • Patel, Rahul;
    • Donahoo, William T.;
    • Bost, Sarah;
    • Lyu, Tianchen;
    • Wu, Yonghui;
    • Hogan, William;
    • Prosperi, Mattia;
    • Dixon, Brian E.;
    • Dabelea, Dana;
    • Utidjian, Levon H.;
    • Crume, Tessa L.;
    • Thorpe, Lorna;
    • Liese, Angela D.;
    • Schatz, Desmond A.;
    • Atkinson, Mark A.;
    • Haller, Michael J.;
    • Shenkman, Elizabeth A.
    Publication type:
    Article
    45
    46

    Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
    By:
    • Hong, Jun Hwa;
    • Kim, Myung Jin;
    • Min, Kyung Wan;
    • Won, Jong Chul;
    • Kim, Tae Nyun;
    • Lee, Byung‐Wan;
    • Kang, Jun Goo;
    • Kim, Jae Hyeon;
    • Park, Jung Hwan;
    • Ku, Bon Jeong;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Shon, Ho Sang;
    • Lee, Woo Je;
    • Park, Joong‐Yeol
    Publication type:
    Article
    47
    48
    49
    50